Psymposia: Rick Doblin’s Psychedelic Dreams
Summary: MAPS Founder Rick Doblin, Ph.D., speaks with Psymposia about how a dream helped strengthen his decision to become a psychedelic researcher and therapist. Originally appearing here.
All News
The Veteran: Psychedelics for PTSD: What a Long Strange Trip It’s Been
Summary: Military veteran Virgil Huston publishes a firsthand account of his experience receiving MDMA-assisted psychotherapy in a MAPS-sponsored clinical trial, highlighting how the treatment helped him …
Inverse: The PTSD Experts are Dropping MDMA in the Hopes Ecstacy Can Overcome Fear
Summary: Inverse interviews Dr. Mathew Hoskins about his experience participating in MAPS’ ongoing Phase 1 study of MDMA-assisted psychotherapy for therapists in training to conduct clinical trials …
The News & Observer: In Reversal, Wasserman Schultz Votes in Favor of Medical Pot Amendment
Summary: The News & Observer reports on U.S. Rep. Debbie Wasserman Schultz’s recent decision to support military veterans’ access to medical marijuana programs after MAPS received final …
A Plus: Researchers are Diving into the World of Psychedelic Drugs, and Compelling Results are Arriving
Summary: A Plus reports on MAPS-sponsored clinical studies into the potential benefits of using LSD and MDMA as adjuncts to psychotherapy for treating a variety of mental health issues. The article explores …
The Science Explorer: In a Historic Move, DEA Grants Full Approval for First-Ever Clinical Marijuana Trial for PTSD
Summary: The Science Explorer reports on the Drug Enforcement Administration (DEA)’s recent approval of MAPS’ clinical trial of medical marijuana for U.S. military veterans with chronic, treatment-resistant …
PsyPost: Scientific Review Finds MDMA Therapy as Effective as Exposure Therapy for PTSD Patients
Summary: Psychology Research News highlights new research comparing MDMA-assisted psychotherapy and Prolonged Exposure Therapy as treatments for posttraumatic stress disorder (PTSD). Researchers from University …
Popular Science: DEA Approves First Trial of Medical Marijuana for PTSD
Summary: Popular Science reports on the Drug Enforcement Administration (DEA)’s recent approval of MAPS’ clinical trial of medical marijuana for U.S. military veterans with chronic, treatment-resistant …
International Business Times: DEA Approves Further Research That Directs PTSD to Medical Marijuana
Summary: International Business Times reports on the Drug Enforcement Administration (DEA)’s recent approval of MAPS’ clinical trial of medical marijuana for U.S. military veterans with chronic, …
Medical Daily: The War on Drugs May Have Misrepresented Psychedelics; Here’s Why That Matters
Summary: Medical Daily explores the resurgence of psychedelic research in the 21st century, highlighting new potential treatments for depression, anxiety, posttraumatic stress disorder (PTSD), and addiction. …
Metro Active: Federal Approval Brings MDMA From Club to Clinic
Summary: Metro Active interviews attendees of a recent Global Psychedelic Dinner in Silicon Valley, highlighting why people support MAPS’ fundraising initiative to purchase one kilogram of pharmaceutical …
Newsletter: May 11, 2016
DEA Approves Clinical Trial of Medical Marijuana for PTSD Worldwide benefit events raise over $141,000 for GMP MDMA purchase May 11, 2016 Dear friends and supporters, Thank you for subscribing to the Multidisciplinary …